InterCure Ltd. (INCR.TA)
ILA 517.4
(-1.45%)
ILA 517.4
(-1.45%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 150.16 Million ILS | -33.92% |
| 2022 | 102.15 Million ILS | 75.81% |
| 2021 | 58.1 Million ILS | 103.04% |
| 2020 | 28.61 Million ILS | -64.94% |
| 2019 | 81.61 Million ILS | 731.96% |
| 2018 | 9.81 Million ILS | 776.56% |
| 2017 | 1.11 Million ILS | -20.07% |
| 2016 | 1.4 Million ILS | -41.3% |
| 2015 | 2.38 Million ILS | -59.57% |
| 2014 | 5.89 Million ILS | -29.3% |
| 2013 | 8.34 Million ILS | -3.52% |
| 2012 | 8.64 Million ILS | -21.23% |
| 2011 | 10.98 Million ILS | -27.28% |
| 2010 | 15.1 Million ILS | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 15.57 Million ILS | -65.26% |
| 2024 Q2 | 15.57 Million ILS | 0.0% |
| 2023 Q4 | 44.82 Million ILS | -21.37% |
| 2023 FY | 67.5 Million ILS | -33.92% |
| 2023 Q1 | 26.34 Million ILS | -3.96% |
| 2023 Q2 | 25.92 Million ILS | -1.6% |
| 2023 Q3 | 57 Million ILS | 119.91% |
| 2022 Q3 | 30.87 Million ILS | 25.0% |
| 2022 Q4 | 27.43 Million ILS | -11.15% |
| 2022 FY | 102.15 Million ILS | 75.81% |
| 2022 Q1 | 19.15 Million ILS | -11.1% |
| 2022 Q2 | 24.69 Million ILS | 28.96% |
| 2021 Q2 | 11.52 Million ILS | 25.09% |
| 2021 Q4 | 21.54 Million ILS | 36.08% |
| 2021 FY | 58.1 Million ILS | 103.04% |
| 2021 Q1 | 9.21 Million ILS | 16.86% |
| 2021 Q3 | 15.83 Million ILS | 37.41% |
| 2020 FY | 28.61 Million ILS | -64.94% |
| 2020 Q2 | 6.38 Million ILS | -1.96% |
| 2020 Q3 | 7.83 Million ILS | 22.6% |
| 2020 Q1 | 6.51 Million ILS | 58.23% |
| 2020 Q4 | 7.88 Million ILS | 0.63% |
| 2019 Q3 | 14.53 Million ILS | -2.91% |
| 2019 Q1 | 47.99 Million ILS | 1070.85% |
| 2019 Q2 | 14.97 Million ILS | -68.81% |
| 2019 FY | 81.61 Million ILS | 731.96% |
| 2019 Q4 | 4.11 Million ILS | -71.67% |
| 2018 Q4 | 4.09 Million ILS | 0.0% |
| 2018 Q2 | 1.78 Million ILS | 0.0% |
| 2018 FY | 9.81 Million ILS | 776.56% |
| 2018 Q1 | 1.78 Million ILS | 18.53% |
| 2018 Q3 | 4.09 Million ILS | 129.38% |
| 2017 Q4 | 1.5 Million ILS | -0.0% |
| 2017 FY | 1.11 Million ILS | -20.07% |
| 2017 Q3 | 1.5 Million ILS | 66.54% |
| 2017 Q2 | 905.21 Thousand ILS | -3.69% |
| 2017 Q1 | 939.88 Thousand ILS | 145.59% |
| 2016 FY | 1.4 Million ILS | -41.3% |
| 2016 Q1 | 321.34 Thousand ILS | -39.44% |
| 2016 Q2 | 320.04 Thousand ILS | -0.41% |
| 2016 Q3 | 386.7 Thousand ILS | 20.83% |
| 2016 Q4 | 382.7 Thousand ILS | -1.04% |
| 2015 Q2 | 551.83 Thousand ILS | -14.96% |
| 2015 Q4 | 530.59 Thousand ILS | -16.64% |
| 2015 Q3 | 636.51 Thousand ILS | 15.34% |
| 2015 Q1 | 648.91 Thousand ILS | 26.07% |
| 2015 FY | 2.38 Million ILS | -59.57% |
| 2014 Q2 | 2 Million ILS | -2.31% |
| 2014 Q1 | 2.05 Million ILS | 198.62% |
| 2014 FY | 5.89 Million ILS | -29.3% |
| 2014 Q4 | 514.71 Thousand ILS | -52.01% |
| 2014 Q3 | 1.07 Million ILS | -46.5% |
| 2013 Q1 | 3.12 Million ILS | 16.14% |
| 2013 Q2 | 2.88 Million ILS | -7.74% |
| 2013 FY | 8.34 Million ILS | -3.52% |
| 2013 Q3 | 1.78 Million ILS | -38.3% |
| 2013 Q4 | 687.16 Thousand ILS | -61.4% |
| 2012 Q1 | 2.17 Million ILS | 0.0% |
| 2012 Q3 | 1.43 Million ILS | -34.8% |
| 2012 FY | 8.64 Million ILS | -21.23% |
| 2012 Q4 | 2.69 Million ILS | 87.82% |
| 2012 Q2 | 2.19 Million ILS | 1.02% |
| 2011 FY | 10.98 Million ILS | -27.28% |
| 2010 FY | 15.1 Million ILS | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Cannabotech LTD | 15.36 Million ILA | -877.141% |